{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:59:30Z","timestamp":1791489570290,"version":"4.3.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Crigler-Najjar syndrome (CNS) is an exceedingly rare autosomal recessive disease with an estimated incidence of 1 in a million live births. CNS type 1 (CNS1) is the most severe form, characterized by severe unconjugated hyperbilirubinemia since birth due to the absence of hepatic uridine 5'-diphosphate glucuronyltransferase (UGT1A1) activity. Daily phototherapy (PT) and liver transplant (LT) are the mainstays of therapy. Here, we present a higher-than-expected incidence of CNS1 in Croatia (6,1 in a million). In the last 31 years, we treated eight CNS1 patients from five families with no reported consanguinity. Four patients are descendants of an isolated enclave in Kosovo with a small gene pool and a high potential for inbreeding. Severe unconjugated hyperbilirubinemia was verified in a neonatal period and PT was initiated. Four patients underwent LT from living-related donors. One of them had unsuccessful hepatocyte transplantation earlier. LT was successful in three patients, and one patient died due to primary graft dysfunction. Four patients are currently treated with 9\u201312\u2005h daily PT with inconsistent disease control, and gradually increasing bilirubin. One patient developed kernicterus before LT, while others have normal psychomotor development and no neurologic impairment. Genetic testing of the UGT1A1 gene in six patients from three families revealed three different homozygous mutations (c.722_723 delAG, c.717_718 delAG, and c.1021 C &amp;gt;T), all previously described in other populations. There is a possibility of the founder effect as an explanation for the higher incidence of CNS1 in at least a subgroup of Croatians.<\/jats:p>","DOI":"10.3389\/fped.2023.1276349","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T15:41:35Z","timestamp":1697816495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Case report: Crigler-Najjar syndrome type 1 in Croatia\u2014more than a one in a million: a case series"],"prefix":"10.3389","volume":"11","author":[{"given":"Matea","family":"Kova\u010di\u0107 Perica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Todori\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedo","family":"Mar\u010dinkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"D\u017eepina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna Natalija","family":"Ani\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mrzljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurica","family":"Vukovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"B1","first-page":"169","article-title":"Congenital familial nonhemolytic jaundice with kernicterus","volume":"10","author":"Crigler","year":"1952","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J Biol Chem"},{"key":"B3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/21678707.2018.1495558","article-title":"Advances in understanding disease mechanisms and potential treatments for crigler-najjar syndrome","volume":"6","author":"Bortolussi","year":"2018","journal-title":"Expert Opin Orphan Drugs"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/hep.30959","article-title":"Crigler-Najjar syndrome type 1: pathophysiology, natural history, and therapeutic frontier","volume":"71","author":"Strauss","year":"2020","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.siny.2014.12.008","article-title":"The clinical syndrome of bilirubin-induced neurologic dysfunction","volume":"20","author":"Bhutani","year":"2015","journal-title":"Semin Fetal Neonatal Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(58)91849-X","article-title":"Influence of light on the hyperbilirubinaemia of infants","volume":"1","author":"Cremer","year":"1958","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/hep.510240205","article-title":"Current therapy for crigler-najjar syndrome type 1: report of a world registry","volume":"24","author":"Van der Veere","year":"1996","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/liv.15239","article-title":"Disease burden and management of crigler-najjar syndrome: report of a world registry","volume":"42","author":"Aronson","year":"2022","journal-title":"Liver Int"},{"key":"B9","year":""},{"key":"B10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/jgh.14853","article-title":"Disease burden of crigler-najjar syndrome: systematic review and future perspectives","volume":"35","author":"Dhawan","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/humu.21133","article-title":"Crigler-Najjar syndrome in the Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants","volume":"31","author":"Sneitz","year":"2010","journal-title":"Hum Mutat"},{"key":"B12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00431-005-0055-2","article-title":"Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with crigler-najjar disease","volume":"165","author":"Strauss","year":"2006","journal-title":"Eur J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/s0022-3468(03)00273-2","article-title":"Treatment of crigler-najjar type 1 disease: relevance of early liver transplantation","volume":"38","author":"Schauer","year":"2003","journal-title":"J Pediatr Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MPG.0000000000002952","article-title":"Living related liver transplantation for metabolic liver diseases in children","volume":"72","author":"Sood","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/TP.0b013e31818bc0c4","article-title":"Pediatric liver transplantation for metabolic liver disease: experience at king\u2019s college hospital","volume":"87","author":"Sze","year":"2009","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/pr.2017.284","article-title":"Human hepatocyte transplantation for liver disease: current status and future perspectives","volume":"83","author":"Iansante","year":"2018","journal-title":"Pediatr Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/MPG.0000000000001843","article-title":"Hepatic parenchymal injury in crigler-najjar type I","volume":"66","author":"Mitchell","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/sj.ejhg.5201989","article-title":"The Tunisian population history through the crigler-najjar type I syndrome","volume":"16","author":"Petit","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"B19","first-page":"543","article-title":"Mendelian Diseases and conditions in Croatian island populations: historic records and new insights","volume":"47","author":"Saftic","year":"2006","journal-title":"Croat Med J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.15291\/geoadria.131","article-title":"Janjevo and janjevci\u2014from Kosovo to Zagreb","volume":"9","author":"Siljkovic","year":"2004","journal-title":"Geoadria"},{"key":"B21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bcmd.2013.01.003","article-title":"Gilbert and crigler najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database","volume":"50","author":"Canu","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/humu.9322","article-title":"Spectrum of UGT1A1 mutations in crigler-najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation","volume":"25","author":"Servedio","year":"2005","journal-title":"Hum Mutat"},{"key":"B23","first-page":"306","article-title":"Identification of the deletions in the UGT1A1 gene of the patients with crigler-najjar syndrome type I from Slovakia","volume":"26","author":"Zmet\u00e1kov\u00e1","year":"2007","journal-title":"Gen Physiol Biophys"},{"key":"B24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/jmg.37.9.712","article-title":"Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene","volume":"37","author":"Iolascon","year":"2000","journal-title":"J Med Genet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","article-title":"The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence","volume":"7","author":"Mackenzie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"B26","first-page":"722","article-title":"Cosegregation of intragenic markers with a novel mutation that causes crigler-najjar syndrome type I: implication in carrier detection and prenatal diagnosis","volume":"53","author":"Moghrabi","year":"1993","journal-title":"Am J Hum Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1034\/j.1399-0004.2003.00136.x","article-title":"Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with crigler-najjar syndrome type I and gilbert\u2019s syndrome","volume":"64","author":"Maruo","year":"2003","journal-title":"Clin Genet"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1276349\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T15:41:39Z","timestamp":1697816499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1276349\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":27,"alternative-id":["10.3389\/fped.2023.1276349"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1276349","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"article-number":"1276349"}}